Biological Allografts

At Enhanced Wellness we use birth tissue that is screened and donated from healthy female donors, and processed to retain essential growth factors, proteins, and extracellular matrix components that support healing and tissue regeneration.  These allografts serve as natural scaffolds that help the body repair damaged joints, cartilage, and soft tissues by stimulating the body’s own regenerative processes.  Widely used in regenerative medicine, they offer a safe, minimally invasive treatment option to reduce inflammation, promote healing, and improve function without the need to harvest tissue from the patient’s own body, thus avoiding donor-site complications.

When infused, IV allografts offer several benefits in regenerative medicine. Delivered systemically, IV allograft therapies can promote whole-body healing by distributing growth factors, cytokines, and anti-inflammatory agents throughout the circulatory system.  This approach helps reduce systemic inflammation, supports immune modulation, and stimulates tissue regeneration beyond localized injection sites. IV allografts can be particularly helpful for patients with widespread or chronic inflammatory conditions, autoimmune disorders, or those recovering from injury and illness affecting multiple body systems.  Additionally, IV administration avoids local injection site discomfort and is minimally invasive, making it a convenient adjunct to targeted regenerative treatments.

Biological Allografts are sourced and processed under strict ethical and safety standards, making them an effective alternative for conditions like arthritis, tendon injuries, and other health issues.

A good candidate for biological allografts typically includes individuals experiencing joint pain, tendon or ligament injuries, arthritis, or degenerative conditions who are looking for a minimally invasive, natural healing option.  Patients with soft tissue injuries, cartilage damage, or chronic inflammation who seek to avoid surgery or reduce recovery time are also ideal candidates.  Additionally, those with autoimmune conditions or systemic inflammation may benefit, as allografts help modulate inflammation and promote tissue regeneration without the risks associated with harvesting their own tissue.

Candidates should ideally be in good overall health, with conditions suitable for outpatient procedures, and have realistic expectations about gradual improvement over weeks to months.  Consulting with a qualified healthcare provider will help determine if biological allograft therapy is appropriate based on individual injury history and health status.

A typical regenerative therapy session with biological allografts is a minimally invasive outpatient procedure.  The targeted area, such as a joint or soft tissue, is first cleaned and prepped using sterile techniques.  Once the cryopreserved allografts are thawed, a local anesthetic is administered to minimize discomfort, and the allografts are precisely injected into the targeted treatment.

Downtime following biological allograft treatment is generally minimal.  Most patients can resume normal daily activities almost immediately or within a day or two.  Some mild inflammation or soreness at the injection site may occur temporarily but typically resolves quickly.  Full healing and regenerative effects develop gradually over several weeks to months.  This therapy is designed to avoid the extended recovery periods, risks, and complications associated with surgery, making it a safe and convenient option for many patients.

The number of biological allograft sessions needed varies based on the severity and type of the condition being treated, but most patients experience noticeable improvement after a single injection.  Optimal results typically develop gradually over time as the body’s regenerative processes progress, with continued improvements often seen for several months.  In some cases, adjunct therapies like Prolozone or PRP (Platelet-Rich Plasma) may be recommended to enhance and maintain healing.

Most patients experience minimal to no recovery period.  Many can resume their normal activities immediately or within a day or two, with some mild soreness or inflammation being common and temporary.  Patients usually begin to notice symptom relief within 1 to 2 weeks post-treatment, with pain reduction and improved function continuing as tissues regenerate over months.

This timeline may vary depending on individual health, the condition’s severity, and the specific treatment protocol chosen.  Regular follow-up with the healthcare provider helps tailor the treatment plan to the patient’s response and optimize outcomes

Full healing and the regenerative benefits of the allograft develop gradually over weeks to months, as the body responds to the treatment and tissue regeneration progresses.  This minimally invasive approach avoids the risks, long recovery times, and complications associated with surgical procedures.

Biological allografts are generally considered safe because they are carefully screened and processed to minimize risks, but like any medical treatment, there can be potential side effects and reasons they may not be appropriate for everyone.  Common side effects are usually mild and may include temporary soreness, swelling, or inflammation at the injection site.

More rarely, there is a risk of infection or an immune reaction, although rigorous donor screening and sterilization processes greatly reduce these risks.  There is also a very small possibility of disease transmission, but extensive testing and processing standards adhere to strict regulatory guidelines to prevent this.

Biological allografts may not be suitable for individuals who have active infections, severe immune deficiencies, or allergies to any components used in the graft or processing.  Patients with certain autoimmune disorders or those taking immunosuppressive medications should discuss suitability with their healthcare provider.

It is important for patients to provide a full medical history and disclose any health conditions so the healthcare provider can determine if biological allografts are a safe and appropriate option.​